{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:00:08Z","timestamp":1763755208774,"version":"3.45.0"},"reference-count":60,"publisher":"Oncology Nursing Society (ONS)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncology Nursing Forum"],"published-print":{"date-parts":[[2006,1,1]]},"DOI":"10.1188\/06.onf.e27-e35","type":"journal-article","created":{"date-parts":[[2006,3,2]],"date-time":"2006-03-02T15:37:21Z","timestamp":1141313841000},"page":"E27-E35","source":"Crossref","is-referenced-by-count":12,"title":["Cancer Screening and Risk-Reducing Behaviors of Women Seeking Genetic Cancer Risk Assessment for Breast and Ovarian Cancers"],"prefix":"10.1188","volume":"33","author":[{"given":"Deborah J.","family":"MacDonald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Sarna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwen C.","family":"Uman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia","family":"Grant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey N.","family":"Weitzel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2007,1,2]]},"reference":[{"key":"E00001","unstructured":"American Society of Clinical Oncology. (2003). American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility. <i>Journal of Clinical Oncology, 21<\/i>, 2397-2406."},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Austin, L.T., Ahmad, F., McNally, M.J., & Stewart, D.E. (2002). Breast and cervical cancer screening in Hispanic women: A literature review using the Health Belief Model. <i>Women's Health Issues, 12<\/i>, 122-128.","DOI":"10.1016\/S1049-3867(02)00132-9"},{"key":"E00003","doi-asserted-by":"crossref","unstructured":"Bernstein, J.L., Thompson, W.D., Risch, N., & Holford, T.R. (1992). Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. <i>American Journal of Epidemiology, 136<\/i>, 925-936.","DOI":"10.1093\/oxfordjournals.aje.a116565"},{"key":"E00004","doi-asserted-by":"crossref","unstructured":"Bosompra, K., Flynn, B.S., Ashikaga, T., Rairikar, C.J., Worden, J.K., & Solomon, L.J. (2000). Likelihood of undergoing genetic testing for cancer risk: A population-based study. <i>Preventive Medicine, 30<\/i>, 155-166.","DOI":"10.1006\/pmed.1999.0610"},{"key":"E00005","doi-asserted-by":"crossref","unstructured":"Botkin, J.R., Smith, K.R., Croyle, R.T., Baty, B.J., Wylie, J.E., Dutson, D., et al. (2003). Genetic testing for a <i>BRCA1<\/i> mutation: Prophylactic surgery and screening behavior in women 2 years post testing. <i>American Journal of Medical Genetics, 118A<\/i>, 201-209.","DOI":"10.1002\/ajmg.a.10102"},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Boyle, P., Maisonneuve, P., & Autier, P. (2000). Update on cancer control in women. <i>International Journal of Gynaecology and Obstetrics, 70<\/i>, 263-303.","DOI":"10.1016\/S0020-7292(00)00298-8"},{"key":"E00007","doi-asserted-by":"crossref","unstructured":"Bunn, J.Y., Bosompra, K., Ashikaga, T., Flynn, B.S., & Worden, J.K. (2002). Factors influencing intention to obtain a genetic test for colon cancer risk: A population-based study. <i>Preventive Medicine, 34<\/i>, 567-577.","DOI":"10.1006\/pmed.2002.1031"},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"Champion, V.L. (1987). The relationship of breast self-examination to Health Belief Model variables. <i>Research in Nursing and Health, 10<\/i>, 375-382.","DOI":"10.1002\/nur.4770100605"},{"key":"E00009","doi-asserted-by":"crossref","unstructured":"Champion, V.L. (1993). Instrument refinement for breast cancer screening behaviors. <i>Nursing Research, 42<\/i>, 139-143.","DOI":"10.1097\/00006199-199305000-00003"},{"key":"E00010","doi-asserted-by":"crossref","unstructured":"Cho, E., Spiegelman, D., Hunter, D.J., Chen, W.Y., Stampfer, M.J., Colditz, G.A., et al. (2003). Premenopausal fat intake and risk of breast cancer. <i>Journal of the National Cancer Institute, 95<\/i>, 1079-1085.","DOI":"10.1093\/jnci\/95.14.1079"},{"key":"E00011","doi-asserted-by":"crossref","unstructured":"Claus, E.B., Risch, N., & Thompson, W.D. (1994). Autosomal dominant inheritance of early-onset breast cancer: Implications for risk prediction. <i>Cancer, 73<\/i>, 643-651.","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5"},{"key":"E00012","unstructured":"Daly, M. (1999). NCCN practice guidelines: Genetics\/familial high-risk cancer screening. <i>Oncology, 13<\/i>, 161-183."},{"key":"E00013","unstructured":"DiGianni, L.M., Kim, H.T., Emmons, K., Gelman, R., Kalkbrenner, K.J., & Garber, J.E. (2003). Complementary medicine use among women enrolled in a genetic testing program. <i>Cancer Epidemiology, Biomarkers and Prevention, 12<\/i>, 321-326."},{"key":"E00014","unstructured":"Easton, D.F., Bishop, D.T., Ford, D., Crockford, G.P., & the Breast Cancer Linkage Consortium. (1993). Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. <i>American Journal of Human Genetics, 52<\/i>, 678-701."},{"key":"E00015","unstructured":"Fishbein, M., Triandis, H.C., Kanfer, F.H., Becker, M., Middlestadt, S.E., & Eichler, A. (2001). Factors influencing behavior and behavior change. In A. Baum, T.A. Revenson, & J.E. Singer (Eds.), <i>Handbook of health psychology<\/i> (pp. 3-17). Mahwah, NJ: Lawrence Erlbaum."},{"key":"E00016","doi-asserted-by":"crossref","unstructured":"Fisher, B., Costantino, J.P., Wickerham, D.L., Redmond, C.K., Kavanah, M., Cronin, W.M., et al. (1998). Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. <i>Journal of the National Cancer Institute, 90<\/i>, 1371-1388.","DOI":"10.1093\/jnci\/90.18.1371"},{"key":"E00017","doi-asserted-by":"crossref","unstructured":"Ford, D., Easton, D.F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., et al. (1998). Genetic heterogeneity and penetrance analysis of the <i>BRCA1<\/i> and <i>BRCA2<\/i> genes in breast cancer families. The Breast Cancer Linkage Consortium. <i>American Journal of Human Genetics, 62<\/i>, 676-689.","DOI":"10.1086\/301749"},{"key":"E00018","doi-asserted-by":"crossref","unstructured":"Frank, T.S., Deffenbaugh, A.M., Reid, J.E., Hulick, M., Ward, B.E., Lingenfelter, B., et al. (2002). Clinical characteristics of individuals with germline mutations in <i>BRCA1<\/i> and <i>BRCA2<\/i>: Analysis of 10,000 individuals. <i>Journal of Clinical Oncology, 20<\/i>, 1480-1490.","DOI":"10.1200\/JCO.2002.20.6.1480"},{"key":"E00019","doi-asserted-by":"crossref","unstructured":"Gail, M.H., Brinton, L.A., Byar, D.P., Corle, D.K., Green, S.B., Schairer, C., et al. (1989). Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. <i>Journal of the National Cancer Institute, 81<\/i>, 1879-1886.","DOI":"10.1093\/jnci\/81.24.1879"},{"key":"E00020","doi-asserted-by":"crossref","unstructured":"Hartmann, L.C., Degnim, A., & Schaid, D.J. (2004). Prophylactic mastectomy for <i>BRCA1\/2<\/i> carriers: Progress and more questions. <i>Journal of Clinical Oncology, 22<\/i>, 981-983.","DOI":"10.1200\/JCO.2004.01.925"},{"key":"E00021","doi-asserted-by":"crossref","unstructured":"Hartmann, L.C., Schaid, D.J., Woods, J.E., Crotty, T.P., Myers, J.L., Arnold, P.G., et al. (1999). Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. <i>New England Journal of Medicine, 340<\/i>, 77-84.","DOI":"10.1056\/NEJM199901143400201"},{"key":"E00022","unstructured":"International Society of Nurses in Genetics, Inc. (1998). <i>Statement on the scope and standards of genetics clinical nursing practice<\/i>. Washington, DC: American Nurses Publishing."},{"key":"E00023","doi-asserted-by":"crossref","unstructured":"Isaacs, C., Peshkin, B.N., Schwartz, M., Demarco, T.A., Main, D., & Lerman, C. (2002). Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. <i>Breast Cancer Research and Treatment, 71<\/i>, 103-112.","DOI":"10.1023\/A:1013800409238"},{"key":"E00024","doi-asserted-by":"crossref","unstructured":"Jacobs, L.A. (2002). Health beliefs of first-degree relatives of individuals with colorectal cancer and participation in health maintenance visits: A population-based survey. <i>Cancer Nursing, 25<\/i>, 251-265.","DOI":"10.1097\/00002820-200208000-00001"},{"key":"E00025","doi-asserted-by":"crossref","unstructured":"Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R.C., Ghafoor, A., et al. (2005). Cancer statistics, 2005. <i>CA: A Cancer Journal for Clinicians, 55<\/i>, 10-30.","DOI":"10.3322\/canjclin.55.1.10"},{"key":"E00026","doi-asserted-by":"crossref","unstructured":"Katapodi, M.C., Lee, K.A., Facione, N.C., & Dodd, M.J. (2004). Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: A meta-analytic review. <i>Preventive Medicine, 38<\/i>, 388-402.","DOI":"10.1016\/j.ypmed.2003.11.012"},{"key":"E00027","doi-asserted-by":"crossref","unstructured":"King, M.C., Marks, J.H., & Mandell, J.B. (2003). Breast and ovarian cancer risks due to inherited mutations in <i>BRCA1<\/i> and <i>BRCA2. Science, 302<\/i>, 643-646.","DOI":"10.1126\/science.1088759"},{"key":"E00028","doi-asserted-by":"crossref","unstructured":"Kriege, M., Brekelmans, C.T., Boetes, C., Besnard, P.E., Zonderland, H.M., Obdeijn, I.M., et al. (2004). Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. <i>New England Journal of Medicine, 351<\/i>, 427-437.","DOI":"10.1056\/NEJMoa031759"},{"key":"E00029","doi-asserted-by":"crossref","unstructured":"Kurzer, M.S. (2003). Phytoestrogen supplement use by women. <i>Journal of Nutrition, 133<\/i>, 1983S-1986S.","DOI":"10.1093\/jn\/133.6.1983S"},{"key":"E00030","doi-asserted-by":"crossref","unstructured":"Leitch, A.M., Dodd, G.D., Costanza, M., Linver, M., Pressman, P., McGinnis, L., et al. (1997). American Cancer Society guidelines for the early detection of breast cancer: Update 1997. <i>CA: A Cancer Journal for Clinicians, 47<\/i>, 150-153.","DOI":"10.3322\/canjclin.47.3.150"},{"key":"E00031","unstructured":"Lu, L.J., Anderson, K.E., Grady, J.J., Kohen, F., & Nagamani, M. (2000). Decreased ovarian hormones during a soya diet: Implications for breast cancer prevention. <i>Cancer Research, 60<\/i>, 4112-4121."},{"key":"E00032","unstructured":"MacDonald, D.J. (2002). Women's decisions regarding management of breast cancer risk. <i>Medsurg Nursing, 11<\/i>, 183-186."},{"key":"E00033","doi-asserted-by":"crossref","unstructured":"MacDonald, D.J., Sarna, L., Uman, G.C., Grant, M., & Weitzel, J.N. (2005). Health beliefs of women with and without breast cancer seeking genetic cancer risk assessment. <i>Cancer Nursing, 28<\/i>, 372-379.","DOI":"10.1097\/00002820-200509000-00006"},{"key":"E00034","doi-asserted-by":"crossref","unstructured":"McGarvey, E.L., Clavet, G.J., Johnson, J.B., II, Butler, A., Cook, K.O., & Pennino, B. (2003). Cancer screening practices and attitudes: Comparison of low-income women in three ethnic groups. <i>Ethnicity and Health, 8<\/i>, 71-82.","DOI":"10.1080\/13557850303556"},{"key":"E00035","doi-asserted-by":"crossref","unstructured":"Meiser, B., Butow, P., Barratt, A., Friedlander, M., Kirk, J., Gaff, C., et al. (2000). Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer. <i>Breast Cancer Research and Treatment, 59<\/i>, 101-111.","DOI":"10.1023\/A:1006330631832"},{"key":"E00036","doi-asserted-by":"crossref","unstructured":"Metcalfe, K., Lynch, H.T., Ghadirian, P., Tung, N., Olivotto, I., Warner, E., et al. (2004). Contralateral breast cancer in <i>BRCA1<\/i> and <i>BRCA2<\/i> mutation carriers. <i>Journal of Clinical Oncology, 22<\/i>, 2328-2335.","DOI":"10.1200\/JCO.2004.04.033"},{"key":"E00037","doi-asserted-by":"crossref","unstructured":"Narod, S.A., Brunet, J.S., Ghadirian, P., Robson, M., Heimdal, K., Neuhausen, S.L., et al. (2000). Tamoxifen and risk of contralateral breast cancer in <i>BRCA1<\/i> and <i>BRCA2<\/i> mutation carriers: A case-control study. Hereditary Breast Cancer Clinical Study Group. <i>Lancet, 356<\/i>, 1876-1881.","DOI":"10.1016\/S0140-6736(00)03258-X"},{"key":"E00038","doi-asserted-by":"crossref","unstructured":"Narod, S.A., Dube, M.P., Klijn, J., Lubinski, J., Lynch, H.T., Ghadirian, P., et al. (2002). Oral contraceptives and the risk of breast cancer in <i>BRCA1<\/i> and <i>BRCA2<\/i> carriers. <i>Journal of the National Cancer Institute, 94<\/i>, 1773-1779.","DOI":"10.1093\/jnci\/94.23.1773"},{"key":"E00039","doi-asserted-by":"crossref","unstructured":"Narod, S.A., & Offit, K. (2005). Prevention and management of hereditary breast cancer. <i>Journal of Clinical Oncology, 23<\/i>, 1656-1663.","DOI":"10.1200\/JCO.2005.10.035"},{"key":"E00040","unstructured":"National Comprehensive Cancer Network. (2005). <i>Genetic\/familial high-risk assessment: Breast and ovarian<\/i>. Retrieved May 31, 2005, from <a target=\"_blank\" href='http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/genetics_screening.pdf'>http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/genetics_screening.pdf<\/a>"},{"key":"E00041","doi-asserted-by":"crossref","unstructured":"NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer. (1995). <i>JAMA, 273<\/i>, 491-497.","DOI":"10.1001\/jama.273.6.491"},{"key":"E00042","unstructured":"Oncology Nursing Society. (2004a). <i>Cancer predisposition genetic testing and risk assessment counseling<\/i>. Retrieved October 1, 2004, from <a target=\"_blank\" href='http:\/\/www.ons.org\/publications\/positions\/documents\/pdfs\/CancerPredisposition.pdf'>http:\/\/www.ons.org\/publications\/positions\/documents\/pdfs\/CancerPredisposition.pdf<\/a>"},{"key":"E00043","unstructured":"Oncology Nursing Society. (2004b). <i>The role of the oncology nurse in cancer genetic counseling<\/i>. Retrieved October 1, 2004, from <a target=\"_blank\" href='http:\/\/www.ons.org\/publications\/positions\/documents\/pdfs\/CancerGenetic.pdf'>http:\/\/www.ons.org\/publications\/positions\/documents\/pdfs\/CancerGenetic.pdf<\/a>"},{"key":"E00044","doi-asserted-by":"crossref","unstructured":"Paley, P.J., Swisher, E.M., Garcia, R.L., Agoff, S.N., Greer, B.E., Peters, K.L., et al. (2001). Occult cancer of the fallopian tube in <i>BRCA-1<\/i> germline mutation carriers at prophylactic oophorectomy: A case for recommending hysterectomy at surgical prophylaxis. <i>Gynecologic Oncology, 80<\/i>, 176-180.","DOI":"10.1006\/gyno.2000.6071"},{"key":"E00045","unstructured":"Rebbeck, T.R. (2000). Prophylactic oophorectomy in <i>BRCA1<\/i> and <i>BRCA2<\/i> mutation carriers. <i>Journal of Clinical Oncology, 18<\/i>(21, Suppl.), 100S-103S."},{"key":"E00046","doi-asserted-by":"crossref","unstructured":"Rebbeck, T.R., Friebel, T., Lynch, H.T., Neuhausen, S.L., van't Veer, L., Garber, J.E., et al. (2004). Bilateral prophylactic mastectomy reduces breast cancer risk in <i>BRCA1<\/i> and <i>BRCA2<\/i> mutation carriers: The PROSE study group. <i>Journal of Clinical Oncology, 22<\/i>, 1055-1062.","DOI":"10.1200\/JCO.2004.04.188"},{"key":"E00047","doi-asserted-by":"crossref","unstructured":"Rebbeck, T.R., Lynch, H.T., Neuhausen, S.L., Narod, S.A., Van't Veer, L., Garber, J.E., et al. (2002). Prophylactic oophorectomy in carriers of <i>BRCA1<\/i> or <i>BRCA2<\/i> mutations. <i>New England Journal of Medicine, 346<\/i>, 1616-1622.","DOI":"10.1056\/NEJMoa012158"},{"key":"E00048","doi-asserted-by":"crossref","unstructured":"Robson, M., Svahn, T., McCormick, B., Borgen, P., Hudis, C.A., Norton, L., et al. (2005). Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in <i>BRCA1<\/i> or <i>BRCA2<\/i>: A clinic-based series. <i>Cancer, 103<\/i>, 44-51.","DOI":"10.1002\/cncr.20728"},{"key":"E00049","doi-asserted-by":"crossref","unstructured":"Schildkraut, J.M., Calingaert, B., Marchbanks, P.A., Moorman, P.G., & Rodriguez, G.C. (2002). Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk. <i>Journal of the National Cancer Institute, 94<\/i>, 32-38.","DOI":"10.1093\/jnci\/94.1.32"},{"key":"E00050","unstructured":"SGO Committee. (2005). Society of Gynecologic Oncologists Clinical Practice Committee statement on prophylactic salpingo-oophorectomy. <i>Gynecologic Oncology, 98<\/i>, 179-181."},{"key":"E00051","doi-asserted-by":"crossref","unstructured":"Smith, I.E., Dowsett, M., Ebbs, S.R., Dixon, J.M., Skene, A., Blohmer, J.U., et al. (2005). Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: The immediate pre-operative anastrozole, tamoxifen, or combined with tamoxifen (IMPACT) multicenter double-blind randomized trial. <i>Journal of Clinical Oncology, 23<\/i>, 5108-5116.","DOI":"10.1200\/JCO.2005.04.005"},{"key":"E00052","doi-asserted-by":"crossref","unstructured":"Smith, R.A., Cokkinides, V., & Eyre, H.J. (2005). American Cancer Society guidelines for the early detection of cancer, 2005. <i>CA: A Cancer Journal for Clinicians, 55<\/i>, 31-44.","DOI":"10.3322\/canjclin.55.1.31"},{"key":"E00053","doi-asserted-by":"crossref","unstructured":"Smith, R.A., Mettlin, C.J., Davis, K.J., & Eyre, H. (2000). American Cancer Society guidelines for the early detection of cancer. <i>CA: A Cancer Journal for Clinicians, 50<\/i>, 34-49.","DOI":"10.3322\/canjclin.50.1.34"},{"key":"E00054","doi-asserted-by":"crossref","unstructured":"Struewing, J.P., Hartge, P., Wacholder, S., Baker, S.M., Berlin, M., McAdams, M., et al. (1997). The risk of cancer associated with specific mutations of <i>BRCA1<\/i> and <i>BRCA2<\/i> among Ashkenazi Jews. <i>New England Journal of Medicine, 336<\/i>, 1401-1408.","DOI":"10.1056\/NEJM199705153362001"},{"key":"E00055","doi-asserted-by":"crossref","unstructured":"Tavani, A., Bosetti, C., Dal Maso, L., Giordano, L., Franceschi, S., & La Vecchia, C. (2004). Influence of selected hormonal and lifestyle factors on familial propensity to ovarian cancer. <i>Gynecologic Oncology, 92<\/i>, 922-926.","DOI":"10.1016\/j.ygyno.2003.11.038"},{"key":"E00056","doi-asserted-by":"crossref","unstructured":"Tinley, S.T., Houfek, J., Watson, P., Wenzel, L., Clark, M.B., Coughlin, S., et al. (2004). Screening adherence in <i>BRCA1\/2<\/i> families is associated with primary physicians' behavior. <i>American Journal of Medical Genetics, 125A<\/i>, 5-11.","DOI":"10.1002\/ajmg.a.20431"},{"key":"E00057","doi-asserted-by":"crossref","unstructured":"Wargovich, M.J., Woods, C., Hollis, D.M., & Zander, M.E. (2001). Herbals, cancer prevention and health. <i>Journal of Nutrition, 131<\/i>(11, Suppl.), 3034S-3036S.","DOI":"10.1093\/jn\/131.11.3034S"},{"key":"E00058","doi-asserted-by":"crossref","unstructured":"Whittemore, A.S., Balise, R.R., Pharoah, P.D., Dicioccio, R.A., Oakley-Girvan, I., Ramus, S.J., et al. (2004). Oral contraceptive use and ovarian cancer risk among carriers of <i>BRCA1<\/i> or <i>BRCA2<\/i> mutations. <i>British Journal of Cancer, 91<\/i>, 1911-1915.","DOI":"10.1038\/sj.bjc.6602239"},{"key":"E00059","doi-asserted-by":"crossref","unstructured":"Winer, E.P., Hudis, C., Burstein, H.J., Wolff, A.C., Pritchard, K.I., Ingle, J.N., et al. (2005). American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status report 2004. <i>Journal of Clinical Oncology, 23<\/i>, 619-629.","DOI":"10.1200\/JCO.2005.09.121"},{"key":"E00060","unstructured":"Ziogas, A., Gildea, M., Cohen, P., Bringman, D., Taylor, T.H., Seminara, D., et al. (2000). Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. <i>Cancer Epidemiology, Biomarkers and Prevention, 9<\/i>, 103-111."}],"container-title":["Oncology Nursing Forum"],"original-title":[],"link":[{"URL":"http:\/\/ons.metapress.com\/index\/H307166720R5525Q.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:51:47Z","timestamp":1763754707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/onf\/33\/2\/cancer-screening-and-risk-reducing-behaviors-women-seeking-genetic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,1]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,1,1]]}},"alternative-id":["H307166720R5525Q"],"URL":"https:\/\/doi.org\/10.1188\/06.onf.e27-e35","relation":{},"ISSN":["0190-535X","1538-0688"],"issn-type":[{"type":"print","value":"0190-535X"},{"type":"electronic","value":"1538-0688"}],"subject":[],"published":{"date-parts":[[2006,1,1]]}}}